Izotropic (STU:1R3) Buyback Yield %: -4.73 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:1R3 Izotropic Corp STU:1R3
37 GF Score
Price €0.14
! 2 Warning Signs
View Full Analysis

What is Izotropic Buyback Yield %?

Izotropic STU:1R3 -2.07% 37 Buyback Yield % is -4.73 as of Jul. 15, 2026. GuruFocus rates STU:1R3 with a GF Score™ of 37/100. The stock has 2 warning signs investors should review. Among 90 Medical Diagnostics & Research companies, Izotropic ranks worse than 54.44% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Izotropic's current buyback yield was -4.73%.

Izotropic Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Izotropic's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Izotropic Buyback Yield % Chart

Izotropic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only -11.15 -1.75 -11.67 -12.36 -6.50

Izotropic Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.34 -5.95 -4.46 -3.66 -5.10

STU:1R3 vs TMO, DHR, IDXX: Buyback Yield % Comparison

For the Diagnostics & Research subindustry, Izotropic's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Izotropic Buyback Yield % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Izotropic's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Izotropic's Buyback Yield % falls into.


STU:1R3
37GF Score
Izotropic Corp STU:1R3
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Izotropic Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Izotropic's Buyback Yield for the fiscal year that ended in Apr. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0.586) / 9.0132
=-6.50%

Izotropic's annualized Buyback Yield for the quarter that ended in Jan. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.541) / 9.3882225
=-5.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -4.73 mean?
Izotropic (STU:1R3) has a Buyback Yield % of -4.73 as of Jul. 15, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Izotropic and its competitors. According to the industry distribution chart, Izotropic ranks #49 out of 90 companies in the Medical Diagnostics & Research industry, placing it in the top 54.4%.
Is Izotropic's Buyback Yield % too high?
Izotropic's current Buyback Yield % is -4.73. Based on the distribution chart, Izotropic ranks #49 out of 90 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Izotropic has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Izotropic's Buyback Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Izotropic ranks #49 out of 90 companies for Buyback Yield %. This places Izotropic in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Diagnostics & Research company?
A good Buyback Yield % depends on the Medical Diagnostics & Research industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Izotropic and its competitors. Izotropic's current Buyback Yield % is -4.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Izotropic stock overvalued right now?
Izotropic (STU:1R3) has a current Buyback Yield % of -4.73. The current Buyback Yield % is -4.73. Izotropic's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Izotropic (STU:1R3), the current Buyback Yield % is -4.73 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Izotropic Business Description

Other Exchanges IZOZF:USAIZO:Canada
Address 800 - 15355 24th Avenue, Suite 424, Surrey, BC, CAN, V4A 2H9
Izotropic Corp is a research and development company specializing in cancer research and early detection for breast cancer. It is engaged in advancing breast cancer imaging through the commercialization of medical imaging technologies. The company's current focus is on the commercialization of its first medical imaging device, IzoView, a dedicated Breast CT Imaging System, developed to provide high resolution, true 3D volumetric visualization of the breast without compression for breast cancer detection and diagnosis.
37GF Score

Get the complete analysis for STU:1R3

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price